Trade AbbVie ^ABBV

Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness

Dividend Stocks To Follow Now - March 15th - Markets Daily

Is AbbVie Inc. (ABBV) A Good Stock to Buy Now?

My 5 Favorite Dividend Stocks to Buy Right Now

AbbVie Inc. $ABBV is Crawford Investment Counsel Inc.'s 2nd Largest Position

AbbVie Inc. $ABBV Shares Sold by Calydon Capital

Cannell & Spears LLC Decreases Stake in AbbVie Inc. $ABBV

Bridgefront Capital LLC Sells 6,779 Shares of AbbVie Inc. $ABBV

Chevy Chase Trust Holdings LLC Trims Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Shares Bought by Cinctive Capital Management LP - Daily Political

Cannell & Spears LLC Cuts Position in AbbVie Inc. $ABBV - Daily Political

Banco Bilbao Vizcaya Argentaria S.A. Sells 22,214 Shares of AbbVie Inc. $ABBV - Stock Observer

Ausdal Financial Partners Inc. Buys 3,506 Shares of AbbVie Inc. $ABBV - Daily Political

Bimzelx Trial Win Raises New Questions For AbbVie Skyrizi Outlook

Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer

von Borstel & Associates Inc. Takes Position in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Shares Acquired by Zuckerman Investment Group LLC - Markets Daily

AbbVie Inc. $ABBV Stock Position Decreased by Prudential PLC

Temasek Holdings Private Ltd Buys 25,496 Shares of AbbVie Inc. $ABBV - Stock Observer

Regal Investment Advisors LLC Cuts Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Diligent Investors LLC

Prudential PLC Sells 16,705 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's Why

Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy?

AbbVie (NYSE:ABBV) Trading Down 2.5% - Here's What Happened - Stock Observer

11 Debt Free Halal Stocks to Buy

If You Have $500,000 Saved at 60, Here's The Sort of Monthly Income You Can Count On

Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Nottingham biotech lands licensing deal with pharma giant AbbVie | TheBusinessDesk.com

Martingale Asset Management L P Sells 14,724 Shares of AbbVie Inc. $ABBV - Markets Daily

Invesco Ltd. Raises Stock Holdings in AbbVie Inc. $ABBV

Sei Investments Co. Increases Holdings in AbbVie Inc. $ABBV

Advisory Research Inc. Buys 9,880 Shares of AbbVie Inc. $ABBV

AbbVie Inc. (NYSE:ABBV) Receives Average Rating of "Moderate Buy" from Brokerages

AbbVie CEO Robert Michael got big pay hike in 2025

The Best Dividend Stocks to Buy and Hold Forever

Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer

AbbVie (NYSE:ABBV) Shares Down 1% - What's Next? - Daily Political

Avalo Therapeutics CEO Teases Q2 Top-Line Data for AVTX-009 Phase 2b HS LOTUS Trial at Conference - Markets Daily

AbbVie Inc. $ABBV Shares Sold by Van ECK Associates Corp

Douglass Winthrop Advisors LLC Grows Stock Position in AbbVie Inc. $ABBV - Markets Daily

Bokf Na Sells 8,422 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Holdings Cut by Bokf Na | MarketBeat

RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages

AbbVie Reports Promising Results from Phase 1 Study of ABBV-295

AbbVie Inc. $ABBV Holdings Cut by Bokf Na - Stock Observer

How The Narrative For AbbVie (ABBV) Is Shifting On Immunology Growth And Competition Risks

Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight

Josh Brown: Biotech growth stocks immune to disruption risk

AbbVie's ABBV-295 Obesity Data Sparks Fresh Interest In Valuation

Market Downturn: 2 Stocks to Buy and Hold Through Any Storm

SageView Advisory Group LLC Buys 13,883 Shares of AbbVie Inc. $ABBV - Markets Daily

Mackenzie Financial Corp Sells 99,604 Shares of AbbVie Inc. $ABBV

Franklin Resources Inc. Trims Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Franklin Resources Inc. - Stock Observer

Kepler Cheuvreux Suisse SA Takes $7.54 Million Position in AbbVie Inc. $ABBV - Daily Political

Immunophenotypic changes following menin inhibition in acute myeloid leukemia

abbvie hosts national media conclave on world glaucoma week

AbbVie's GLP-1 challenger shows early weight loss promise - Crain's Chicago Business

Capital International Investors Has $2.48 Billion Stock Holdings in AbbVie Inc. $ABBV - Markets Daily

Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - Markets Daily

Claret Asset Management Corp Has $27.53 Million Position in AbbVie Inc. $ABBV - Markets Daily

Is It Too Late To Consider AbbVie (ABBV) After A Strong Multi Year Run?

Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - Stock Observer

Elahere (AbbVie: mirvetuximab soravtansine-gynx) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Bank of Montreal Can Raises Stock Position in AbbVie Inc. $ABBV

ABBV: Future Returns Will Depend On Immunology Encore And Deal Optionality Uncertainty

Richard Bernstein Advisors LLC Cuts Stock Holdings in AbbVie Inc. $ABBV - Daily Political

B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?

Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study

AbbVie (NYSE:ABBV) Shares Down 1% Following Insider Selling

Biotech is resistant to AI disruption. Josh Brown likes these two stocks in the industry

REGENXBIO To Report Duchenne Muscular Dystrophy Trial Results In Early Q2 2026

AbbVie Trial Updates Add Context To Valuation And Growth Outlook

Sienna Gestion Boosts Stock Holdings in AbbVie Inc. $ABBV

AbbVie Reports Positive Topline Results In Phase 1 Study For ABBV-295 In Weight Management

AbbVie Inc. $ABBV Shares Purchased by Schroder Investment Management Group

Swiss National Bank Trims Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by LGT Group Foundation

Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks

AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn's Disease

First Trust Advisors LP Sells 1,007,670 Shares of AbbVie Inc. $ABBV

Private Advisor Group LLC Sells 3,553 Shares of AbbVie Inc. $ABBV - Daily Political

LGT Group Foundation Increases Position in AbbVie Inc. $ABBV - Daily Political

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer

This 5-Star ETF Pays Monthly Dividends and Has Never Missed in 19 Years

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript

Natixis Advisors LLC Sells 4,569 Shares of AbbVie Inc. $ABBV

Korea Investment CORP Acquires 188,587 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Rhenman & Partners Asset Management AB

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk